The Cancer and Molecular Pathology and Genomics MSc at Queen Mary University of London is a full-time, one-year program that provides an advanced understanding of the molecular pathology of common human malignancies and drives an exploration of the impacts of genomics on the clinical management of solid tumours and haematological malignancies.Course Content: The course offers a deep understanding of the molecular pathology and genomics of human malignancies. It incorporates practical training using state-of-art molecular pathology and genomics platforms. Subjects under study range from cancer biology, molecular oncology, to pathogenesis of major types of solid and hematological malignancies.Key Modules: The course consists of modules such as Cancer Genomics, Molecular Scoring of Tumours, Cancer Therapeutics and Research Project. The Cancer Sciences Research Project is a key component of the course, which involves original research in the laboratories of researchers based at the Barts Cancer Institute.Accreditations: This course qualifies students to engage in individual research projects which can offer the suitable experience and mentoring needed to facilitate PhD studies or careers in the genomics of cancer diagnostics and therapeutics.Future Careers: The acquired skills and knowledge can lead students to multiple career opportunities. Graduates of the program can find employment in various fields including academia, pharmaceutical industry, bio-industry, molecular diagnostics laboratories and clinical-cancer genetic counselling.For more information on this course, please visit the official course page: Cancer and Molecular Pathology and Genomics MSc | Queen Mary University London